Budesonide inhalation suspension versus methylprednisolone for treatment of moderate bronchial asthma attacks

Budesonide inhalation suspension versus methylprednisolone

May 05, 2015 · Administration of steroids for bronchial asthma attacks should be minimized to prevent adverse effects. Budesonide inhalation suspension (BIS) is used for the long-term management of bronchial asthma in children aged from 6 months to 5 years . There have been a few reports on the use of BIS in patients with acute asthma attacks, but a consensus is yet to be reached on its role in the …

[PDF]

Budesonide inhalation suspension versus methylprednisolone

Background: Owing to their side effects, administration of steroids for bronchial asthma attacks should be minimized. We investigated whether budesonide inhalation suspension (BIS) could replace intravenous steroid administration for the treatment of moderate bronchial asthma attacks. Subjects and Methods: The subjects were children aged 5 years and younger hospitalized for moderate bronchial asthma …

Budesonide inhalation suspension versus methylprednisolone

We investigated whether budesonide inhalation suspension (BIS) could replace intravenous steroid administration for the treatment of moderate bronchial asthma attacks. The subjects were children aged 5 years and younger hospitalized for moderate bronchial asthma attacks.

Budesonide inhalation suspension versus methylprednisolone

Budesonide inhalation suspension, 0.25 mg, 0.50 mg, and 1.0 mg twice daily, is an effective and safe treatment for young children with inhaled steroid-dependent, persistent asthma.

Top read allergy-immunology articles of 2015 – #13

Budesonide inhalation suspension versus methylprednisolone for treatment of moderate bronchial asthma attacks. World Allergy Organization Journal. Yanagida N, et al.

Nebulized budesonide versus oral steroid in severe

Noriyuki Yanagida, Morimitsu Tomikawa, Akinori Shukuya, Masamichi Iguchi and Motohiro Ebisawa, Budesonide inhalation suspension versus methylprednisolone for treatment of moderate bronchial asthma attacks, World Allergy Organization Journal, 8, 1, (1), (2015).

Medscape | World Allergy Organiz J – Publication Information

Budesonide inhalation suspension versus methylprednisolone for treatment of moderate bronchial asthma attacks. May 05, 2015 [ MEDLINE Abstract] Severity of allergic rhinitis and asthma development in children. April 23, 2015 [ MEDLINE Abstract] Urticarial vasculitis induced by OTC diet pills: a case report. April 16, 2015 [ MEDLINE Abstract]

Efficacy of nebulized budesonide compared to oral

To evaluate the efficacy of nebulized budesonide compared to oral prednisolone early in the emergency room management of acute asthma, we conducted a double-blind, placebo-controlled trial. Eighty children, 2 years to 12 years of age, with acute moderate attacks of asthma…

Published in: Acta Paediatrica · 2007Authors: Devidayal · Sunit Singhi · Lata Kumar · M JayshreeAbout: Respiratory disease · Oral administration · Corticosteroid · Chemotherapy · Budesonide
[PDF]

Budesonide Inhalation Suspension in Adults W ith P oorly

during BIS treatment compared with the previous year .Clinical improvements in FEV 1 occurred in 58% of these patients with long-standing disease .Reported improvements in asthma control and pulmonary function suggest that BIS V ol. 9, No .1 & 2, 2009 ¥ The Journal of Applied Researc h Budesonide Inhalation Suspension

Pulmicort (budesonide) | Asthma.net

Pulmicort (budesonide) is an inhaled corticosteroid and approved for the long-term treatment of asthma. Pulmicort comes as a dry powder inhaler (Pulmicort Flexhaler) and as a liquid suspension for use with a jet nebulizer (Pulmicort Respules).1,2.

Budesonide inhalation Uses, Side Effects & Warnings

Budesonide inhalation can pass into breast milk and may harm a nursing baby. Tell your doctor if you are breast-feeding a baby. Budesonide inhalation can affect growth in children. Tell your doctor if your child is not growing at a normal rate while using this medicine. Budesonide inhalation is not approved for use by anyone younger than 6 years old.